Pharma Aids Limited (DSE:PHARMAID)

Pharma Aids Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	57.78	11.2	32.72	15.12	24.91
Cash & Short-Term Investments	57.78	11.2	32.72	15.12	24.91
Cash Growth	416.04%	-65.78%	116.46%	-39.30%	24.68%
Accounts Receivable	165.07	160.91	129.58	127.1	123.51
Other Receivables	-	23.24	23.84	28.06	29.31
Receivables	165.07	184.16	153.43	155.16	152.82
Inventory	77.97	63.56	61.84	56.83	63.67
Prepaid Expenses	-	-	-	-	14.53
Other Current Assets	112.18	228.26	172.08	87.37	51.62
Total Current Assets	419.09	487.17	420.07	314.48	307.54
Property, Plant & Equipment	257.32	93.77	60.12	66.86	72.27
Total Assets	676.41	580.94	480.19	381.34	379.82

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	33.55	3.88	5.55	1.66	1.42
Accrued Expenses	23.36	42.83	38.23	29.72	32.13
Short-Term Debt	14.33	27.3	18.16	11.47	0.99
Current Income Taxes Payable	39.38	68.57	73.6	50.05	33.32
Other Current Liabilities	29.01	3.81	1.75	3.44	3.34
Total Current Liabilities	139.62	146.39	137.3	96.34	71.2
Long-Term Deferred Tax Liabilities	2.16	2.19	0.05	0.22	0.27
Other Long-Term Liabilities	25.09	-	-	0	-
Total Liabilities	166.87	148.58	137.35	96.56	71.47

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	31.2	31.2	31.2	31.2	31.2
Retained Earnings	444.57	367.4	311.65	253.58	275.56
Comprehensive Income & Other	33.76	33.76	-	-	1.59
Shareholders' Equity	509.54	432.36	342.85	284.78	308.35
Total Liabilities & Equity	676.41	580.94	480.19	381.34	379.82

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Total Debt	14.33	27.3	18.16	11.47	0.99
Net Cash (Debt)	43.45	-16.1	14.56	3.64	23.92
Net Cash Growth	-	-	299.66%	-84.77%	21.59%
Net Cash Per Share	13.93	-5.16	4.67	1.17	7.67
Filing Date Shares Outstanding	3.12	3.12	3.12	3.12	3.12
Total Common Shares Outstanding	3.12	3.12	3.12	3.12	3.12
Working Capital	279.47	340.78	282.77	218.14	236.35
Book Value Per Share	163.31	138.58	109.89	91.28	98.83
Tangible Book Value	509.54	432.36	342.85	284.78	308.35
Tangible Book Value Per Share	163.31	138.58	109.89	91.28	98.83
Land	-	36	0.08	0.08	0.08
Buildings	-	16.16	14.29	14.29	14.29
Machinery	-	195.48	193.89	193.79	191.74

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error